Krystof Bankiewicz is a leader in AAV gene therapy who has brought multiple AAV therapies to the clinic. He is the Kinetics Foundation Chair in Translational Research and Professor in Residence of Neurological Surgery and Neurology at the University of California at San Francisco (UCSF). Dr. Bankiewicz is also Vice Chair for Research in the department of neurosurgery and Director of Interventional Neurology Center at UCSF. Dr. Bankiewicz has both industry and academic experience, is an inventor on numerous patents and has published more than 180 peer-reviewed research articles. He has considerable experience in supervising multi-investigator translational programs and is a principal investigator on several multicenter, multi-investigator grants and clinical trials. He has supervised a total of 35 postdoctoral fellows and manages a core research group of 20 people, including technicians, postdoctoral fellows and senior scientists. Throughout his career, Dr. Bankiewicz has maintained a strong focus on the development of translational approaches to gene and cell replacement therapies, and he has displayed the ability to synthesize distinct technologies into powerful new approaches to the treatment of serious diseases, including brain cancer, Parkinson’s disease, Huntington’s disease, Alzheimer’s disease, pediatric neurotransmitter deficiency and lysosomal storage disorders. Dr. Bankiewicz holds a Doctor of Medicine from Jagiellonian University in Crakow and a Doctor of Philosophy, a D.Sc., from the Institute of Neurology and Psychiatry in Warsaw, Poland and professor title by the President of Republic of Poland. Dr. Bankiewicz was a recipient of Fogarty Fellowship and trained at the National Institutes of Neurological Disorders and Stroke at the the National Institutes of Health (NIH) in Bethesda, Md.

science